[HTML] nih.gov

[HTML][HTML] PP01-M01

Y Nagai, N Miyakawa, H Takuwa, Y Hori, K Oyama… - Metabolism, 2019 - ncbi.nlm.nih.gov
Objectives Designer Receptors Exclusively Activated by Designer Drug (DREADDs) is one
of the chemogenetic technologies that afford a means to selectively and remotely control the …
相关文章
[PDF] core.ac.uk

[PDF][PDF] PP01-M01

Y Nagai, N Miyakawa, H Takuwa, Y Hori, K Oyama, B Ji… - Metabolism, 2019 - core.ac.uk
Abstract Objectives: Designer Receptors Exclusively Activated by Designer Drug
(DREADDs) is one of the chemogenetic technologies that afford a means to selectively and …